한글목차

세계의 오메가 3 시장 규모는 2025년에 약 43억 6,220만 달러, 2030년까지 77억 5,640만 달러에 이를 것으로 예측되어 CAGR 12.2%의 성장이 전망됩니다.

오메가3 시장은 심혈관 건강, 인지 기능, 시력, 관절 건강, 유아의 뇌 발달에 있어 EPA와 DHA의 역할에 대한 인식이 높아지고, 예방 의학 및 기능성 영양에 대한 소비자의 관심이 높아지면서 큰 모멘텀을 얻고 있습니다. 유아 조제분유 부문은 인지 및 신체 발달에 있어 조기 영양의 중요성, 특히 DHA 및 기타 필수 영양소의 역할에 대한 부모들의 인식이 높아지고, 북미, 유럽, 중국 등 여러 지역에서 조제분유에 DHA 강화를 의무화하거나 권장하는 규정과 권고가 제정되면서 폭발적인 성장세를 보이고 있습니다. 폭발적인 성장세를 보이고 있습니다. 그러나 연구개발 활동에 소요되는 높은 비용과 불안정한 어유 가격이 오메가3 시장 성장에 어려움을 겪을 것으로 예측됩니다.

오메가 3 시장의 혼란은 기업에 기회를 가져올 수 있습니다.

오메가3 시장은 근본적으로 변화하고 있으며, 기업들에게 새로운 기회가 열리고 있습니다. 가장 큰 변화 중 하나는 어유 공급에 대한 우려를 해소하고 비건 및 친환경 소비자들이 공감할 수 있는 해조류 오일과 발효 기반 오메가3와 같은 지속 가능한 식물성 원료로 전환하는 것입니다. 영유아의 DHA 강화 의무화, 심혈관계 및 인지기능 강화에 대한 폭넓은 승인과 같은 규제 업데이트도 선진국과 신흥국 시장 모두에서 안정적인 수요를 촉진하고 있습니다. 한편, 마이크로 캡슐화와 같은 기술 발전은 안정성과 풍미를 향상시켜 오메가3를 새로운 식음료 용도에 접목할 수 있게 해줍니다.

오메가3는 기존의 건강보조식품 외에도 의약품, 반려동물사료, 양식업 등 다양한 분야에서 점점 더 많이 사용되고 있습니다. 신경 및 심혈관 건강에 사용되는 의약품 등급 제제가 성장세를 보이고 있으며, 고급 반려동물사료와 강화 양식 사료가 큰 폭의 성장세를 보이고 있습니다. 편리한 형태의 기능성 영양 제품(구미, 분말, RTD)에 대한 수요 증가와 남미 및 아시아태평양의 건강 보조 식품에 대한 소비 지출 증가와 함께 이러한 추세는 시장 상황을 재정의하고 있습니다. 조달, 제품 개발, 지속가능성을 혁신하는 기업들은 신흥국 시장에서 성장할 수 있는 기회가 있습니다.

건강기능식품 부문은 가장 빠르게 성장하는 부문 중 하나가 될 것으로 예측됩니다.

건강기능식품 카테고리는 소비자들이 예방의학에 관심을 갖고 심장, 뇌, 눈, 관절 건강에 도움이 되는 솔루션으로 눈을 돌리면서 오메가3 시장의 큰 성장 동력 중 하나가 되고 있습니다. 건강 강조 표시에 대한 규제 당국의 승인에 힘입어 건강기능식품은 신뢰성과 편의성을 제공하며, 소프트젤, 구미젤, 파우더 등 전달 형태가 발전함에 따라 모든 연령대의 사람들에게 매력적으로 다가갈 수 있습니다. 이러한 건강 의식, 고령화, 제품 창의성의 시너지 효과로 인해 건강 보조 식품에서 오메가3에 대한 견고하고 안정적인 수요가 촉진되고 있습니다.

액체 오메가3가 오메가3 시장에서 큰 비중을 차지할 것으로 예측됩니다.

시중에 판매되는 오메가3의 대부분은 어유, 해조류, 크릴오일에서 추출한 것으로, 원래 액체이며 영양제, 유아용 조제분유, 기능성 식품, 의약품에 주로 사용됩니다. 액체는 순도가 높고 생체 이용률이 높으며 소프트젤, 에멀젼, 강화 액체 식품에 더 쉽게 배합할 수 있습니다. 구미, 분말, 베이커리 용도로 사용되면서 건조 제형(분말, 마이크로 캡슐화 오메가3)이 증가하고 있는 반면, 액체는 가장 비용 효율적이고 대량 생산이 가능하며 산업 분야에 관계없이 즉시 사용할 수 있기 때문에 계속해서 큰 시장 점유율을 차지하고 있습니다.

EPA(eicosapentaenoic acid) 부문이 크게 성장할 것으로 예측됩니다.

EPA는 중성지방 농도 감소, 염증 감소, 심혈관 기능 전반의 개선 등 심장 건강에 도움이 되는 것으로 나타났습니다. 이러한 건강 효과에 대한 소비자의 인식이 높아지면서 EPA가 함유된 오메가3 보충제 및 강화 식품 및 음료에 대한 수요가 증가하고 있으며, 이는 오메가3 시장 확대에 기여하고 있습니다.

세계의 오메가3 시장에 대해 조사 분석했으며, 주요 촉진요인과 억제요인, 경쟁 구도, 향후 동향 등의 정보를 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 지견

• 오메가 3 시장 기업에 있어서 매력적인 기회
• 북미의 오메가 3 시장 : 원료별, 국가별
• 오메가 3 시장 : 유형별
• 오메가 3 시장 : 용도별
• 오메가 3 시장 : 원료별, 지역별
• 오메가 3 시장 : 지역 현황

제5장 시장 개요

• 서론
• 거시경제 지표
  • 예방 의료 지출
  • 노년 인구 증가
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
• 식품 및 음료 성분/첨가물에 대한 생성형 AI의 영향
  • 식품 및 음료 성분/첨가물에서의 생성형 AI 사용
  • 식품 및 음료 성분/첨가물에서의 생성형 AI 사례 연구
  • 오메가 3 시장에 대한 AI/생성형 AI의 영향
  • 생성형 AI에 임하는 인접 에코시스템

제6장 산업 동향

• 서론
• 2025년 미국 관세의 영향 - 오메가 3 시장
  • 서론
  • 주요 관세율
  • 오메가 3 시장 혼란
  • 가격 영향 분석
  • 국가/지역에 대한 영향
  • 다양한 용도에 대한 영향
• 밸류체인 분석
  • 연구 및 제품 개발
  • 조달
  • 생산 및 가공
  • 유통
  • 마케팅 및 영업
  • 최종사용자
• 무역 분석
  • HS코드 1504 수입 시나리오
  • HS코드 1504 수출 시나리오
• 기술 분석
  • 주요 기술
  • 보완 기술
  • 인접 기술
• 가격 결정 분석
  • 오메가 3 최종 제품 평균 판매 가격 : 제품 유형별
  • 평균 판매 가격 동향 : 지역별
• 생태계 분석
  • 수요측
  • 공급측
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 특허 분석
• 주요 컨퍼런스 및 이벤트(2025년-2026년)
• 규제 상황
  • 규제기관, 정부기관, 기타 조직
  • 규제
• Porter의 Five Forces 분석
• 주요 이해관계자와 구입 기준
• 사례 연구 분석
• 투자 및 자금조달 시나리오

제7장 오메가 3 시장 : 유형별

• 서론
• 도코사헥사엔산
• 다가 불포화 지방산
• 알파 리놀렌산

제8장 오메가 3 시장 : 원료별

• 서론
• 해양
• 식물

제9장 오메가 3 시장 : 용도별

• 서론
• 식이보충제
• 기능성 식품 및 음료
• 의약품
• 유아용 조제분유
• 애완동물 사료 및 사료

제10장 오메가 3 시장 : 형태별

• 서론
• 건조
• 액체

제11장 오메가 3 시장 : 제조 기술별

• 서론
• 추출
  • 정제 및 정화
  • 농축 및 변환
  • 캡슐화 및 안정화
  • 발효 및 바이오테크놀러지

제12장 오메가 3 시장 : 지역별

• 서론
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 노르웨이
  • 이탈리아
  • 스페인
  • 네덜란드
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주 및 뉴질랜드
  • 기타 아시아태평양
• 남미
  • 브라질
  • 아르헨티나
  • 기타 남미
• 기타 지역
  • 아프리카
  • 중동

제13장 경쟁 구도

• 개요
• 주요 시장 진출기업의 전략/강점(2020년-2024년)
• 매출 분석
• 시장 점유율 분석
• 기업 평가와 재무 지표
• 브랜드 및 제품 비교
• 기업 평가 매트릭스 : 주요 기업(2024년)
• 기업 평가 매트릭스 : 스타트업/중소기업(2024년)
• 경쟁 시나리오

제14장 기업 개요

• 주요 기업
  • DSM-FIRMENICH
  • CARGILL, INCORPORATED
  • BASF SE
  • ADM
  • KERRY GROUP PLC
  • CORBION
  • KD PHARMA GROUP SA
  • AKER BIOMARINE
  • CRODA INTERNATIONAL PLC
  • EVONIK INDUSTRIES AG
  • PELAGIA AS
  • GC RIEBER
  • COOKE AQUACULTURE INC.
  • ALGISYS BIOSCIENCES, INC.
  • POLARIS
• 기타 기업
  • BTSA
  • NOVOSANA EUROPE B.V.
  • GOLDEN OMEGA
  • KINOMEGA BIOPHARM INC.
  • RIMFROST AS
  • ALGARITHM
  • SOLUTEX
  • CELLANA INC.
  • SINOMEGA BIOTECH ENGINEERING CO., LTD.
  • ALGAECYTES LIMITED

제15장 인접 시장과 관련 시장

• 서론
• 조사의 한계
• 기능성 식품 성분 시장
  • 시장의 정의
  • 시장 개요
• 콜라겐 시장
  • 시장의 정의
  • 시장 개요

제16장 부록

영문목차

The omega-3 market is estimated to be USD 4,362.2 million in 2025 and is projected to reach USD 7,756.4 million by 2030, at a CAGR of 12.2%.

The omega-3 market is gaining significant traction, driven by the increasing recognition of the roles of EPA and DHA in cardiovascular health, cognitive function, vision, joint health, and infant brain development, as well as a growing consumer shift toward preventive healthcare and functional nutrition. The infant formula sector has witnessed explosive growth, driven by rising awareness among parents about the importance of early nutrition for cognitive and physical development, particularly the role of DHA and other essential nutrients, and regulatory mandates and recommendations in regions such as Europe, North America, and China requiring or encouraging DHA fortification in infant formula. However, high costs involved in R&D activities and unstable fish oil prices are expected to pose a challenge to the omega-3 market's growth.

Disruptions in the omega-3 market may offer opportunities for players

The omega-3 market is undergoing fundamental shifts, opening up new opportunities for companies. One of the most significant changes is the shift toward sustainable and plant-based sources such as algal oil and fermentation-based omega-3, which eliminate fish oil supply concerns and resonate with vegan and green consumers. Regulatory updates, such as the mandatory fortification of DHA in infant nutrition and broader approvals for cardiovascular and cognitive well-being claims, are also driving steady demand in both developed and emerging markets. Meanwhile, technological advances such as microencapsulation are enhancing stability and flavor, allowing omega-3 to be incorporated in new food and beverage applications.

On the application front, Omega-3 is increasingly being used in pharmaceuticals, pet food, and aquaculture, apart from conventional supplements. Pharma-grade formulations for neurological and cardiovascular health are gaining momentum, while high-end pet food and fortified aquaculture feed are experiencing significant growth. Alongside growing demand for convenience formats of functional nutrition products (gummies, powders, RTDs) and increasing consumer spending on health supplement products in South America and the Asia Pacific, these trends are redefining the landscape of the market. Players who innovate in sourcing, product development, and sustainability have a good chance of securing growth in emerging markets.

The dietary supplement segment is projected to be one of the fastest-growing segments

The dietary supplement category is one of the major growth drivers for the omega-3 market as consumers place greater emphasis on preventive healthcare and turn to convenient solutions for heart, brain, eye, and joint well-being. Supported by regulatory approvals for health claims, supplements offer confidence and convenience, as advancements in delivery forms, such as softgels, gummies, and powders, make them attractive to people of all ages. This synergy of health consciousness, aging population, and product creativity is driving robust and consistent demand for omega-3 in dietary supplements.

The liquid form of omega-3 is expected to hold a larger share of the omega-3 market

The majority of commercial omega-3 comes from fish oil, algal oil, and krill oil, which are naturally liquid forms and commonly used in dietary supplements, infant formula, functional foods, and pharmaceuticals. Liquids can accommodate higher purity, greater bioavailability, and simpler inclusion in soft gels, emulsions, and fortified liquid food. While dry formulations (powders, microencapsulated Omega-3) are increasing as a result of uses in gummies, powders, and bakery applications, the liquid form continues to hold a significant market share as it is the most cost-efficient, mass-produced, and immediately applicable state across industries.

The Eicosapentaenoic Acid (EPA) segment is expected to grow at a significant rate

The EPA has been shown to benefit heart health, including reducing triglyceride levels, decreasing inflammation, and improving overall cardiovascular function. As awareness of these health benefits increases among consumers, there is a growing demand for omega-3 supplements and fortified foods and beverages containing EPA, which contributes to the expansion of the omega-3 market.

The US is estimated to dominate the North American omega-3 market during the forecast period

The US is one of the largest global markets for omega-3. The consumption of omega-3-based products and supplements has increased significantly due to rising consumer awareness of their various health benefits and their availability in the US market. The omega-3 consumption pattern in the US is driven toward categories such as capsules, dietary supplements, and infant formula. However, the country has one of the largest consumer markets in the world. Recently, the EPA/DHA (omega-3) ingredients sector has experienced a surge in product innovations, introducing new omega-3 variants and expanding the utilization of plant-based sources. As consumers increasingly prioritize the health of oceans, there is a growing demand for plant-based omega-3 ingredients within the dietary supplement sector.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the omega-3 market.

• By Company Type: Tier 1-25%, Tier 2-45%, and Tier 3-30%
• By Designation: CXOs-25%, Managers-40%, Executives-35%
• By Region: North America-22%, Europe-28%, Asia Pacific-32%, South America-10% and Rest of the World-8%

Prominent companies in the market include BASF SE (Germany), Cargill, Incorporated (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), AlgaeCytes Limited (UK), and others.

Research Coverage

This research report categorizes the omega-3 market by type (Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), and Alpha-linolenic Acid (ALA)), source (marine [fish, algal, krill, and other marine sources] and plant [nuts & seeds and vegetable oils]), application (dietary supplements, functional foods & beverages, pharmaceuticals, infant formulas, and pet food and feed), form (dry and liquid), manufacturing technology (qualitative) (extraction, refining & purification, concentration & conversion, encapsulation & stabilization, and fermentation & biotechnology), and region (North America, Europe, Asia Pacific, South America, and Rest of the World).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of omega-3 ingredients. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the omega-3 market. This report covers the competitive analysis of upcoming startups in the omega-3 market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscapes, among others.

Reasons to Buy This Report

The report offers market leaders/new entrants information on the closest approximations of the revenue numbers for the overall omega-3 and subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

• Analysis of key drivers (Rising adoption of algal oil and plant-based omega-3 (flaxseed, chia, canola) due to concerns over fish oil sustainability), restraints (lack of clarity among consumers about daily recommended intake and health claims), opportunities (increase in research for development of alternative sources to obtain omega-3), and challenges (highly unstable fish oil prices) influencing the growth of the omega-3 market
• Product Development/Innovation: Detailed insights on research & development activities and new product launches in the omega-3 market
• Market Development: Comprehensive information about lucrative markets-the report analyzes omega-3 across varied regions
• Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the omega-3 market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as BASF SE (Germany), Cargill, Incorporated (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), and other players in the omega-3 market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONS CONSIDERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
  • 1.3.5 UNITS CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Breakdown of primary profiles
    • 2.1.2.3 Key insights from industry experts
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 TOP-DOWN APPROACH
  • 2.2.2 SUPPLY-SIDE ANALYSIS
  • 2.2.3 BOTTOM-UP APPROACH (DEMAND SIDE)
• 2.3 DATA TRIANGULATION AND MARKET BREAKUP
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN OMEGA-3 MARKET
• 4.2 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE AND COUNTRY
• 4.3 OMEGA-3 MARKET, BY TYPE
• 4.4 OMEGA-3 MARKET, BY APPLICATION
• 4.5 OMEGA-3 MARKET, BY SOURCE AND REGION
• 4.6 OMEGA-3 MARKET: REGIONAL SNAPSHOT

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 PREVENTIVE HEALTHCARE EXPENDITURE
  • 5.2.2 GROWING GERIATRIC POPULATION
• 5.3 MARKET DYNAMICS
  • 5.3.1 DRIVERS
    • 5.3.1.1 Growing consumer awareness regarding health benefits
    • 5.3.1.2 Increasing use in food and feed products
      • 5.3.1.2.1 Rising demand for mother and infant nutrition products
      • 5.3.1.2.2 Mandatory inclusion of algal DHA in infant formula
      • 5.3.1.2.3 Growth focus of food processing companies on fortification
      • 5.3.1.2.4 Increasing applications in pet food and feed
    • 5.3.1.3 Shift toward pharmaceutical-grade high-concentrate omega-3 oils in developed markets
    • 5.3.1.4 Emergence of innovative production technologies
  • 5.3.2 RESTRAINTS
    • 5.3.2.1 Declining fish oil supply due to sustainability issues in fisheries
    • 5.3.2.2 Lack of clarity on daily intake recommendations and health claims
  • 5.3.3 OPPORTUNITIES
    • 5.3.3.1 Increasing research on alternative sources
      • 5.3.3.1.1 Rising consumer demand for plant-based products
      • 5.3.3.1.2 Growing focus on microalgae-based omega-3 production
      • 5.3.3.1.3 Side effects and allergies related to fish-based products
    • 5.3.3.2 Favorable regulatory environment
    • 5.3.3.3 Integration of microencapsulation technology
  • 5.3.4 CHALLENGES
    • 5.3.4.1 High costs involved in R&D activities
    • 5.3.4.2 Volatility in fish oil prices
    • 5.3.4.3 Instability of omega-3 oils
• 5.4 IMPACT OF GEN AI ON FOOD & BEVERAGE INGREDIENTS/ADDITIVES
  • 5.4.1 USE OF GEN AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES
  • 5.4.2 CASE STUDIES FOR GENERATIVE AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES
    • 5.4.2.1 Kerry Trendspotter leveraged AI and ML to analyze consumer-generated social media content, identifying and predicting food trends
    • 5.4.2.2 IFF partners with Salus Optima to create personalized nutrition platform using AI to offer customized dietary recommendations based on metabolic health
    • 5.4.2.3 Ingredion utilized cloud-based data analytics, AI, and cloud technology to address challenges in F&B industry
  • 5.4.3 IMPACT OF AI/GENERATIVE AI ON OMEGA-3 MARKET
  • 5.4.4 ADJACENT ECOSYSTEM WORKING ON GENERATIVE AI

6 INDUSTRY TRENDS

• 6.1 INTRODUCTION
• 6.2 IMPACT OF 2025 US TARIFF - OMEGA-3 MARKET
  • 6.2.1 INTRODUCTION
  • 6.2.2 KEY TARIFF RATES
  • 6.2.3 DISRUPTION IN OMEGA-3 MARKET
  • 6.2.4 PRICE IMPACT ANALYSIS
  • 6.2.5 IMPACT ON COUNTRY/REGION
    • 6.2.5.1 US
    • 6.2.5.2 Europe
    • 6.2.5.3 China
  • 6.2.6 IMPACT ON DIFFERENT APPLICATIONS
• 6.3 VALUE CHAIN ANALYSIS
  • 6.3.1 RESEARCH AND PRODUCT DEVELOPMENT
  • 6.3.2 SOURCING
  • 6.3.3 PRODUCTION AND PROCESSING
  • 6.3.4 DISTRIBUTION
  • 6.3.5 MARKETING AND SALES
  • 6.3.6 END USERS
• 6.4 TRADE ANALYSIS
  • 6.4.1 IMPORT SCENARIO OF HS CODE 1504
  • 6.4.2 EXPORT SCENARIO OF HS CODE 1504
• 6.5 TECHNOLOGY ANALYSIS
  • 6.5.1 KEY TECHNOLOGIES
    • 6.5.1.1 Molecular distillation
    • 6.5.1.2 Supercritical CO2 extraction
    • 6.5.1.3 Algae fermentation
  • 6.5.2 COMPLEMENTARY TECHNOLOGIES
    • 6.5.2.1 Stabilization & antioxidant technologies
    • 6.5.2.2 Microencapsulation
  • 6.5.3 ADJACENT TECHNOLOGIES
    • 6.5.3.1 Precision fermentation
    • 6.5.3.2 Synthetic biology & bioprocess engineering
• 6.6 PRICING ANALYSIS
  • 6.6.1 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE
  • 6.6.2 AVERAGE SELLING PRICE TREND, BY REGION
• 6.7 ECOSYSTEM ANALYSIS
  • 6.7.1 DEMAND SIDE
  • 6.7.2 SUPPLY SIDE
• 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 6.9 PATENT ANALYSIS
• 6.10 KEY CONFERENCES AND EVENTS, 2025-2026
• 6.11 REGULATORY LANDSCAPE
  • 6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.11.2 REGULATIONS
    • 6.11.2.1 North America
      • 6.11.2.1.1 US
      • 6.11.2.1.2 Canada
    • 6.11.2.2 Europe
    • 6.11.2.3 Asia Pacific
      • 6.11.2.3.1 China
      • 6.11.2.3.2 Japan
      • 6.11.2.3.3 India
    • 6.11.2.4 South America
      • 6.11.2.4.1 Brazil
      • 6.11.2.4.2 Argentina
      • 6.11.2.4.3 Chile
    • 6.11.2.5 Rest of the World
      • 6.11.2.5.1 South Africa
      • 6.11.2.5.2 UAE
• 6.12 PORTER'S FIVE FORCES ANALYSIS
  • 6.12.1 INTENSITY OF COMPETITIVE RIVALRY
  • 6.12.2 BARGAINING POWER OF SUPPLIERS
  • 6.12.3 BARGAINING POWER OF BUYERS
  • 6.12.4 THREAT OF SUBSTITUTES
  • 6.12.5 THREAT OF NEW ENTRANTS
• 6.13 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 6.13.2 BUYING CRITERIA
• 6.14 CASE STUDY ANALYSIS
  • 6.14.1 VERAMARIS: PIONEERING SUSTAINABLE OMEGA-3 SOLUTIONS IN AQUACULTURE
  • 6.14.2 MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY
  • 6.14.3 AKER BIOMARINE SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY
• 6.15 INVESTMENT AND FUNDING SCENARIO

7 OMEGA-3 MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2030 - USD MILLION)

• 7.1 INTRODUCTION
• 7.2 DOCOSAHEXAENOIC ACID
  • 7.2.1 NEED FOR PROTECTION AGAINST ALZHEIMER'S DISEASE TO DRIVE DEMAND
• 7.3 EICOSAPENTAENOIC ACID
  • 7.3.1 ABILITY TO REDUCE SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND
• 7.4 ALPHA-LINOLENIC ACID
  • 7.4.1 GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND

8 OMEGA-3 MARKET, BY SOURCE (MARKET SIZE & FORECAST TO 2030- USD MILLION & KILOTONS)

• 8.1 INTRODUCTION
• 8.2 MARINE
  • 8.2.1 NEED FOR HEALTHY FETAL DEVELOPMENT IN PREGNANT WOMEN TO DRIVE MARKET
  • 8.2.2 FISH
    • 8.2.2.1 Anchovy
    • 8.2.2.2 Sardine
    • 8.2.2.3 Mackerel
    • 8.2.2.4 Other fish types
  • 8.2.3 ALGAE
    • 8.2.3.1 Schizochytrium sp.
    • 8.2.3.2 Crypthecodinium cohnii
    • 8.2.3.3 Nannochloropsis sp.
    • 8.2.3.4 Other algae types
  • 8.2.4 KRILL
  • 8.2.5 OTHER MARINE SOURCES
• 8.3 PLANT
  • 8.3.1 GROWING USE OF FLAX SEEDS FOR CANCER PREVENTION TO BOOST DEMAND
  • 8.3.2 NUTS & SEEDS
  • 8.3.3 VEGETABLE OILS

9 OMEGA-3 MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2030 - USD MILLION)

• 9.1 INTRODUCTION
• 9.2 DIETARY SUPPLEMENTS
  • 9.2.1 GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIETS TO DRIVE DEMAND
• 9.3 FUNCTIONAL FOODS & BEVERAGES
  • 9.3.1 ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND
  • 9.3.2 DAIRY & DAIRY ALTERNATIVES
  • 9.3.3 BAKERY & CEREAL PRODUCTS
  • 9.3.4 CONFECTIONERY PRODUCTS
  • 9.3.5 MEAT & MEAT PRODUCTS
  • 9.3.6 BEVERAGES
  • 9.3.7 OTHER FUNCTIONAL FOOD PRODUCTS
• 9.4 PHARMACEUTICALS
  • 9.4.1 GROWING NEED TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET
• 9.5 INFANT FORMULAS
  • 9.5.1 RISING CONSUMPTION OF OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND
• 9.6 PET FOOD & FEED
  • 9.6.1 GREATER EMPHASIS ON ENHANCING IMMUNITY IN PETS TO DRIVE MARKET
  • 9.6.2 PET FOOD
  • 9.6.3 ANIMAL FEED

10 OMEGA-3 MARKET, BY FORM (MARKET SIZE & FORECAST TO 2030 - USD MILLION)

• 10.1 INTRODUCTION
• 10.2 DRY
  • 10.2.1 ENCAPSULATED STABILITY MEETS VERSATILE APPLICATIONS
• 10.3 LIQUID
  • 10.3.1 HIGH BIOAVAILABILITY AND EFFICACY TO FUEL DEMAND

11 OMEGA 3 MARKET, BY MANUFACTURING TECHNOLOGY

• 11.1 INTRODUCTION
• 11.2 EXTRACTION
  • 11.2.1 REFINING & PURIFICATION
  • 11.2.2 CONCENTRATION & CONVERSION
  • 11.2.3 ENCAPSULATION & STABILIZATION
  • 11.2.4 FERMENTATION & BIOTECHNOLOGY

12 OMEGA-3 MARKET, BY REGION (MARKET SIZE & FORECAST TO 2030 - USD MILLION & KILOTONS)

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 US
    • 12.2.1.1 Growing incorporation of omega-3 in dietary supplements to drive market
  • 12.2.2 CANADA
    • 12.2.2.1 Increasing application in functional foods & beverages to boost market
  • 12.2.3 MEXICO
    • 12.2.3.1 Growing focus on heart disease prevention to drive market
• 12.3 EUROPE
  • 12.3.1 GERMANY
    • 12.3.1.1 Low fish consumption to boost demand for omega-3-based supplements
  • 12.3.2 UK
    • 12.3.2.1 Increasing focus on preventive healthcare and maintaining cognitive function into older age to drive market
  • 12.3.3 FRANCE
    • 12.3.3.1 Ongoing innovations to boost quality and stability of omega-3-rich oil formulation to drive market
  • 12.3.4 NORWAY
    • 12.3.4.1 Production of genetically modified canola to offer lucrative growth opportunities to market players
  • 12.3.5 ITALY
    • 12.3.5.1 High production of dietary supplements, functional food products, and beverages to boost market
  • 12.3.6 SPAIN
    • 12.3.6.1 Rising consumer awareness and dietary gaps to drive market
  • 12.3.7 NETHERLANDS
    • 12.3.7.1 Growing incidences of depression, autism, and ADHD to drive market
  • 12.3.8 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 CHINA
    • 12.4.1.1 Increasing focus on product innovations and diversification to drive market
  • 12.4.2 INDIA
    • 12.4.2.1 Growing incidences of heart failure to drive market
  • 12.4.3 JAPAN
    • 12.4.3.1 Rising use of innovative formulation technology to create opportunities for omega-3 product manufacturers
  • 12.4.4 AUSTRALIA & NEW ZEALAND
    • 12.4.4.1 Government-led initiatives to increase awareness regarding omega-3 to drive market
  • 12.4.5 REST OF ASIA PACIFIC
• 12.5 SOUTH AMERICA
  • 12.5.1 BRAZIL
    • 12.5.1.1 Rising demand for algal oils to drive market
  • 12.5.2 ARGENTINA
    • 12.5.2.1 Commercialization of omega-3 products to fuel market
  • 12.5.3 REST OF SOUTH AMERICA
• 12.6 REST OF THE WORLD
  • 12.6.1 AFRICA
    • 12.6.1.1 Prevalence of undernutrition among pregnant women and children to drive market
  • 12.6.2 MIDDLE EAST
    • 12.6.2.1 Ongoing innovations in omega-3 products to drive market

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2024
• 13.3 REVENUE ANALYSIS
• 13.4 MARKET SHARE ANALYSIS
• 13.5 COMPANY VALUATION AND FINANCIAL METRICS
• 13.6 BRAND/PRODUCT COMPARISON
• 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 13.7.1 STARS
  • 13.7.2 EMERGING LEADERS
  • 13.7.3 PERVASIVE PLAYERS
  • 13.7.4 PARTICIPANTS
  • 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 13.7.5.1 Company footprint
    • 13.7.5.2 Regional footprint
    • 13.7.5.3 Source footprint
    • 13.7.5.4 Type footprint
    • 13.7.5.5 Application footprint
• 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 13.8.1 PROGRESSIVE COMPANIES
  • 13.8.2 RESPONSIVE COMPANIES
  • 13.8.3 DYNAMIC COMPANIES
  • 13.8.4 STARTING BLOCKS
  • 13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 13.8.5.1 Detailed list of key startups/SMEs
    • 13.8.5.2 Competitive benchmarking of key startups/SMEs
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 PRODUCT LAUNCHES AND ENHANCEMENTS
  • 13.9.2 DEALS
  • 13.9.3 EXPANSIONS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 DSM-FIRMENICH
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products/Solutions/Services offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Product launches and enhancements
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Right to win
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses and competitive threats
  • 14.1.2 CARGILL, INCORPORATED
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products/Solutions/Services offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Deals
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Key strengths
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses and competitive threats
  • 14.1.3 BASF SE
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products/Solutions/Services offered
    • 14.1.3.3 MnM view
      • 14.1.3.3.1 Key strengths
      • 14.1.3.3.2 Strategic choices
      • 14.1.3.3.3 Weaknesses and competitive threats
  • 14.1.4 ADM
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products/Solutions/Services offered
    • 14.1.4.3 MnM view
      • 14.1.4.3.1 Right to win
      • 14.1.4.3.2 Strategic choices
      • 14.1.4.3.3 Weaknesses and competitive threats
  • 14.1.5 KERRY GROUP PLC
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products/Solutions/Services offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Deals
    • 14.1.5.4 MnM view
      • 14.1.5.4.1 Right to win
      • 14.1.5.4.2 Strategic choices
      • 14.1.5.4.3 Weaknesses and competitive threats
  • 14.1.6 CORBION
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products/Solutions/Services offered
    • 14.1.6.3 Recent developments
      • 14.1.6.3.1 Product launches and enhancements
      • 14.1.6.3.2 Expansions
      • 14.1.6.3.3 Other developments
    • 14.1.6.4 MnM view
  • 14.1.7 KD PHARMA GROUP SA
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products/Solutions/Services offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Deals
      • 14.1.7.3.2 Expansions
    • 14.1.7.4 MnM view
  • 14.1.8 AKER BIOMARINE
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products/Solutions/Services offered
    • 14.1.8.3 Recent developments
      • 14.1.8.3.1 Product launches and enhancements
      • 14.1.8.3.2 Deals
      • 14.1.8.3.3 Other developments
    • 14.1.8.4 MnM view
  • 14.1.9 CRODA INTERNATIONAL PLC
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products/Solutions/Services offered
    • 14.1.9.3 MnM view
  • 14.1.10 EVONIK INDUSTRIES AG
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products/Solutions/Services offered
    • 14.1.10.3 Recent developments
      • 14.1.10.3.1 Product launches and enhancements
      • 14.1.10.3.2 Deals
    • 14.1.10.4 MnM view
  • 14.1.11 PELAGIA AS
    • 14.1.11.1 Business overview
    • 14.1.11.2 Products/Solutions/Services offered
    • 14.1.11.3 Recent developments
      • 14.1.11.3.1 Product launches and enhancements
      • 14.1.11.3.2 Other developments
    • 14.1.11.4 MnM view
  • 14.1.12 GC RIEBER
    • 14.1.12.1 Business overview
    • 14.1.12.2 Products/Solutions/Services offered
    • 14.1.12.3 Recent developments
      • 14.1.12.3.1 Product launches and enhancements
      • 14.1.12.3.2 Deals
      • 14.1.12.3.3 Expansions
    • 14.1.12.4 MnM view
  • 14.1.13 COOKE AQUACULTURE INC.
    • 14.1.13.1 Business overview
    • 14.1.13.2 Products/Solutions/Services offered
    • 14.1.13.3 Recent developments
      • 14.1.13.3.1 Deals
    • 14.1.13.4 MnM view
  • 14.1.14 ALGISYS BIOSCIENCES, INC.
    • 14.1.14.1 Business overview
    • 14.1.14.2 Products/Solutions/Services offered
    • 14.1.14.3 Recent developments
      • 14.1.14.3.1 Other developments
    • 14.1.14.4 MnM view
  • 14.1.15 POLARIS
    • 14.1.15.1 Business overview
    • 14.1.15.2 Products/Solutions/Services offered
    • 14.1.15.3 Recent developments
      • 14.1.15.3.1 Product launches and enhancements
      • 14.1.15.3.2 Other developments
    • 14.1.15.4 MnM view
• 14.2 OTHER PLAYERS
  • 14.2.1 BTSA
    • 14.2.1.1 Business overview
    • 14.2.1.2 Products/Solutions/Services offered
    • 14.2.1.3 MnM view
  • 14.2.2 NOVOSANA EUROPE B.V.
    • 14.2.2.1 Business overview
    • 14.2.2.2 Products/Solutions/Services offered
    • 14.2.2.3 Recent developments
      • 14.2.2.3.1 Deals
    • 14.2.2.4 MnM view
  • 14.2.3 GOLDEN OMEGA
    • 14.2.3.1 Business overview
    • 14.2.3.2 Products/Solutions/Services offered
    • 14.2.3.3 Recent developments
      • 14.2.3.3.1 Deals
    • 14.2.3.4 MnM view
  • 14.2.4 KINOMEGA BIOPHARM INC.
    • 14.2.4.1 Business overview
    • 14.2.4.2 Products/Solutions/Services offered
    • 14.2.4.3 MnM view
  • 14.2.5 RIMFROST AS
    • 14.2.5.1 Business overview
    • 14.2.5.2 Products/Solutions/Services offered
    • 14.2.5.3 Recent developments
      • 14.2.5.3.1 Deals
    • 14.2.5.4 MnM view
  • 14.2.6 ALGARITHM
  • 14.2.7 SOLUTEX
  • 14.2.8 CELLANA INC.
  • 14.2.9 SINOMEGA BIOTECH ENGINEERING CO., LTD.
  • 14.2.10 ALGAECYTES LIMITED

15 ADJACENT & RELATED MARKETS

• 15.1 INTRODUCTION
• 15.2 STUDY LIMITATIONS
• 15.3 FUNCTIONAL FOOD INGREDIENTS MARKET
  • 15.3.1 MARKET DEFINITION
  • 15.3.2 MARKET OVERVIEW
• 15.4 COLLAGEN MARKET
  • 15.4.1 MARKET DEFINITION
  • 15.4.2 MARKET OVERVIEW

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS